These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3791605)

  • 1. Treatment of canine pulmonary hypertension: effects of norepinephrine and isoproterenol on pulmonary vascular pressure-flow characteristics.
    Ducas J; Duval D; Dasilva H; Boiteau P; Prewitt RM
    Circulation; 1987 Jan; 75(1):235-42. PubMed ID: 3791605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary vascular effects of hydralazine in a canine preparation of pulmonary thromboembolism.
    Ducas J; Girling L; Schick U; Prewitt RM
    Circulation; 1986 May; 73(5):1050-7. PubMed ID: 3698227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vascular pressure-flow characteristics. Effects of dopamine before and after pulmonary embolism.
    Ducas J; Stitz M; Gu S; Schick U; Prewitt RM
    Am Rev Respir Dis; 1992 Aug; 146(2):307-12. PubMed ID: 1489117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of noradrenaline and isoproterenol on cardiopulmonary function in a canine model of acute pulmonary hypertension.
    Molloy DW; Lee KY; Jones D; Penner B; Prewitt RM
    Chest; 1985 Sep; 88(3):432-5. PubMed ID: 4028855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary vascular pressure-flow plots in canine oleic acid pulmonary edema. Effects of prostaglandin E1 and nitroprusside.
    Leeman M; Lejeune P; Mélot C; Naeije R
    Am Rev Respir Dis; 1988 Aug; 138(2):362-7. PubMed ID: 3143286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of shock in a canine model of pulmonary embolism.
    Molloy WD; Lee KY; Girling L; Schick U; Prewitt RM
    Am Rev Respir Dis; 1984 Nov; 130(5):870-4. PubMed ID: 6497165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.
    Prielipp RC; McLean R; Rosenthal MH; Pearl RG
    Crit Care Med; 1991 Jan; 19(1):60-7. PubMed ID: 1986891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary vascular pressure-flow characteristics in canine pulmonary embolism.
    Hasinoff I; Ducas J; Schick U; Prewitt RM
    J Appl Physiol (1985); 1990 Feb; 68(2):462-7. PubMed ID: 2318757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norepinephrine and phenylephrine effects on right ventricular function in experimental canine pulmonary embolism.
    Hirsch LJ; Rooney MW; Wat SS; Kleinmann B; Mathru M
    Chest; 1991 Sep; 100(3):796-801. PubMed ID: 1889275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cardiopulmonary and renal hemodynamic effects of norepinephrine in canine pulmonary embolism.
    Angle MR; Molloy DW; Penner B; Jones D; Prewitt RM
    Chest; 1989 Jun; 95(6):1333-7. PubMed ID: 2721272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of inhalation of nitroglycerin on hypoxic pulmonary vasoconstriction.
    Bando M; Ishii Y; Kitamura S; Ohno S
    Respiration; 1998; 65(1):63-70. PubMed ID: 9523370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vasodilators on gas exchange in acute canine embolic pulmonary hypertension.
    Delcroix M; Mélot C; Lejeune P; Leeman M; Naeije R
    Anesthesiology; 1990 Jan; 72(1):77-84. PubMed ID: 2297136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hemodynamic responses to intravenous prostaglandin E2 in broiler chickens.
    Stebel S; Wideman RF
    Poult Sci; 2008 Jan; 87(1):138-45. PubMed ID: 18079463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism.
    Prewitt RM; Downes AM; Gu SA; Chan SM; Ducas J
    Chest; 1991 Mar; 99(3):708-14. PubMed ID: 1899825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension.
    Young TE; Lundquist LJ; Chesler E; Weir EK
    Am J Cardiol; 1983 Jan; 51(1):195-200. PubMed ID: 6571766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary vascular resistance in neonatal swine: response to right pulmonary artery occlusion, isoproterenol, and prostaglandin E1.
    Crombleholme TM; Adzick NS; Longaker MT; Bradley SM; Duncan BW; Jennings R; Verrier ED; Harrison MR
    J Pediatr Surg; 1990 Aug; 25(8):861-6. PubMed ID: 2401941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of progressive vascular occlusion on slope and intercept of the pulmonary artery pressure-flow relationship.
    Gu S; Prewitt RM; Schick U; Ducas J
    Angiology; 1995 Jan; 46(1):45-52. PubMed ID: 7818156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant tissue-type plasminogen activator in canine embolic pulmonary hypertension. Effects of bolus versus short-term administration on dynamics of thrombolysis and on pulmonary vascular pressure-flow characteristics.
    Prewitt RM; Shiffman F; Greenberg D; Cook R; Ducas J
    Circulation; 1989 Apr; 79(4):929-38. PubMed ID: 2494007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary vasodilator effects of norepinephrine during the development of chronic pulmonary hypertension in neonatal lambs.
    Jaillard S; Elbaz F; Bresson-Just S; Riou Y; Houfflin-Debarge V; Rakza T; Larrue B; Storme L
    Br J Anaesth; 2004 Dec; 93(6):818-24. PubMed ID: 15465842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pulmonary vascular effects of dopamine, dobutamine, and isoproterenol in unilobar pulmonary edema in dogs.
    Light RB; Ali J; Breen P; Wood LD
    J Surg Res; 1988 Jan; 44(1):26-35. PubMed ID: 3336208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.